1Toth E, Csupor E, Mesz ros S, et al. The effect of intranasal salmon calcitonin therapy on bone mineral density in idiopathic male osteoprosis without vertebral fractures-An open label study [J].Bone,2005, 36(1): 47-51.
2Klibanski A, Adams-Campbell L, Bassford T, et al. NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy [J]. JAMA, 2001,285 (6):785-795.
7Chesnut CH,Majumdar S, Newitt DC, et al. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging:results from the quest study [J]. J Bone Miner Res, 2005,20 (9).. 1548-1561.
4NIH Consensus Development Panel on osteoporosis Prevention, Diagnosis, and Therapy, Osteoporosis Prevention Diagnosis and Therapy [J], JAMA, 2001, 23(6) :785-795.
7Chesnut CH 3rd, Majumdar S, Newitt DC, et al. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study [J]. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study [J]. J Bone Miner Res, 2005, 20(9) : 1548-1561.
8Lyritis GP, Trovas G. Abirritation of Salmoncalcition [J], Bone, 2002,30(5):71-74.
7Klibanski A, Adams-Campbell L, Bass- ford T, et al. NIH consensus development panel on osteopomsis prevention, diagnosis, and therapy [J].JAMA,2001,285(6):785-795.
8Meczekalski B, Czyzyk A. New forms of estregenotherapy in postmenopausal oste oporeds.Pol Merkur Lekarski,2009,27: 77-80.
9Cummings SR, Ettinger B, Delmas PD, et al .The effects oftibolone in older postme nopausal women,N Engl J Med,2008,359: 697-708.
10Janssen HC, Samson MM,Verhaar HJ. Muscle strength and mobility in vitamin D-insufficient female geriatric patients: a randomized controlled trial on vitamin D and calcium supplementation [J]. Aging Clin Exp Res,2010,22:78-84.
